Literature DB >> 24040441

AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice.

Min Zhang1, Wei-Yi Fang, Xin-Kai Qu, Fang Yuan, Wei-Gang Wang, Jian Fei, Zhi-Gang Wang.   

Abstract

Ghrelin/GHS-R axis is known as its role in stimulating growth hormone release. Besides, it is also implicated in the regulation of atherosclerosis (AS), a chronic vascular disease that has been recognized as the main cause of coronary heart disease and cerebrovascular disease. It has been reported that both Ghrelin and AMPK play protective roles in AS by inhibiting the inflammatory response as well as cell proliferation. However, it remains unclear whether AMPK pathway is involved in Ghrelin/GHS-R-mediated inhibition of the inflammatory response and cell proliferation in AS. Here, we established the GHS-R gene knockout mice (GHS-R(-/-)) and found that AMPK activity is notably down-regulated in endothelial cells (ECs) of GHS-R(-/-) mice and the ECs from GHS-R(-/-) mice possess higher proliferative capability than the ECs from wild-type mice. Moreover, AMPK is activated in primary ECs upon Ghrelin induction in vitro. Taking together, the present study unravels that Ghrelin/GHS-R could efficiently activate AMPK in ECs, suggesting a possible mechanism that the roles of Ghrelin/GHS-R in the inhibition of inflammatory response and cell proliferation in AS disease may be partially mediated by activating AMPK.

Entities:  

Keywords:  AMPK; ECs; GHS-R-/-; atherosclerosis; cell proliferation

Mesh:

Substances:

Year:  2013        PMID: 24040441      PMCID: PMC3759483     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

1.  [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.

Authors:  S D Katugampola; Z Pallikaros; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

3.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.

Authors:  Yuxiang Sun; Pei Wang; Hui Zheng; Roy G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

4.  Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.

Authors:  N P E Kadoglou; N Sailer; A Moumtzouoglou; A Kapelouzou; H Tsanikidis; I Vitta; C Karkos; P E Karayannacos; T Gerasimidis; C D Liapis
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-10-15       Impact factor: 2.949

5.  Ghrelin and cardiovascular diseases.

Authors:  Gaigai Zhang; Xinhua Yin; Yongfen Qi; Lakshmana Pendyala; Jack Chen; Dongming Hou; Chaoshu Tang
Journal:  Curr Cardiol Rev       Date:  2010-02

6.  Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice.

Authors:  Eija Kellokoski; Outi Kummu; Raisa Serpi; Petri Lehenkari; Olavi Ukkola; Y Antero Kesäniemi; Sohvi Hörkkö
Journal:  Peptides       Date:  2009-09-12       Impact factor: 3.750

7.  Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin.

Authors:  Min Zhan; Fang Yuan; Hua Liu; Hui Chen; Xingbiao Qiu; Weiyi Fang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-09       Impact factor: 3.848

Review 8.  AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?

Authors:  Madhumita Dandapani; D Grahame Hardie
Journal:  Biochem Soc Trans       Date:  2013-04       Impact factor: 5.407

9.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

Authors:  Gianluca Baldanzi; Nicoletta Filigheddu; Santina Cutrupi; Filomena Catapano; Sara Bonissoni; Alberto Fubini; Daniela Malan; Germano Baj; Riccarda Granata; Fabio Broglio; Mauro Papotti; Nicola Surico; Federico Bussolino; Jorgen Isgaard; Romano Deghenghi; Fabiola Sinigaglia; Maria Prat; Giampiero Muccioli; Ezio Ghigo; Andrea Graziani
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

10.  Atherosclerosis: from biology to pharmacological treatment.

Authors:  Graziano Riccioni; Valeriana Sblendorio
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

View more
  3 in total

1.  Preliminary application of hybrid operation in the treatment of carotid artery stenosis in patients with complex ischemic cerebrovascular diseases.

Authors:  Liyong Zhang; Tao Xing; Fenyang Geng; Lixin Du; Jiyue Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 2.  Research progress of ghrelin on cardiovascular disease.

Authors:  Ming-Jie Yuan; Wei Li; Peng Zhong
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

Review 3.  Effect of Ghrelin on the Cardiovascular System.

Authors:  Hiroshi Hosoda
Journal:  Biology (Basel)       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.